• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 6772 | Ordered by Date (descending)
1 2 3 ... 66 67 68  

Deal: Collaboration or Financing	Date
AmniSure–Qiagen: investment, 201205 acquisition €na	2012-05-03
United States (govt)–Evotec: compound management, 201205– supply compound management services €7.7m for 5y to US EPA by Evotec San Francisco	2012-05-03
Roche–Dako: molecular companion diagnostics, 201205– collab regulatory submission HercepTest + HER2 FISH pharmDx for trastuzumab-DM1 Genentech	2012-05-01
Cardinal Health–Qiagen: molecular diagnostics, 201204– distribution of Qiagen systems + kits to smaller + mid-sized US hospitals by Cardinal Health	2012-04-30
Gen-Probe–Hologic: investment, 201204– acquisition $3.7b in cash $82.75/share ANNOUNCED	2012-04-30
Quotient Bioresearch–Biotrend: sample labelling services, 201204– collab supply of Iodine-125 labelling services by Anawa Trading SA	2012-04-30
Analytical Perspectives of North Carolina–SGS: investment, 201204 acquisition	2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Malaysia	2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Singapore	2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Thailand	2012-04-27
Active Biotech–Evotec: drug discovery services, 201204– service €na expansion medicinal chemistry services drug optimisation	2012-04-26
Innovacell–SEVERAL: investment, 201204– capital increase €8.3m in two tranches	2012-04-26
Rhön-Klinkum–Fresenius: investment, 201204– cash tender offer €3.1b €22.5/share ANNOUNCED	2012-04-26
JnJ–Artes Biotechnology: cell line development, 201204– collab developm + supply of Hansenula cell lines to Crucell for two vaccines	2012-04-24
ConoGenetix–Bavaria (govt): investment, 201204 financing round Series A totalling €1.5m incl returning investor BioM AG	2012-04-23
ConoGenetix–Mey Capital Matrix: investment, 201204 financing round Series A totalling €1.5m incl lead investor Mey Capital Matrix GmbH	2012-04-23
ConoGenetix–SEVERAL: investment, 201204 financing round Series A €1.5m lead investor Mey Capital Matrix + co-investor BioM AG	2012-04-23
AJ Roboscreen–Analytik Jena: investment, 201204 acquisition of remaining shares with resulting 100% ownership by Analytik Jena AG	2012-04-20
KonTEM–High-Tech Gründerfonds: investment, 201204 investment by HTGF	2012-04-17
Oncgnostics–High-Tech Gründerfonds: investment, 201204 seed funding from HTGF + STIFT	2012-04-16
Oncgnostics–SEVERAL: investment, 201204 seed funding from HTGF + STIFT	2012-04-16
Oncgnostics–Thuringia (govt): investment, 201204 seed funding from HTGF + STIFT	2012-04-16
Bayer–KWS: plant breeding, 201204– collab co-developm breeding of herbicide-resistant varieties for weed control system Bayer CropScience	2012-04-12
Aleva Neurotherapeutics–SEVERAL: investment, 201204 financing round Series B CHF4m lead + new investor Banexi Ventures Partners	2012-04-10
Bipharma–Biofrontera: 5-aminolevulinic acid, 201204– excl marketing + distribution of Ameluz in Benelux by Bipharma NV	2012-04-04
ZIM Plant Technology–High-Tech Gründerfonds: investment, 201204 investment by HTGF	2012-04-04
Henkel–4SC: compound screening, 201204– collab computerised screening to identify laundry detergent ingredients 4SC Discovery GmbH	2012-04-02
Thermo Fisher–Peak Scientific: gas generator, 201203 collab Genius 1022 nitrogen generator specifically developed for Thermo’s Q Exactive system	2012-03-30
Allergan–Biofrontera: 5-aminolevulinic acid, 201203– excl marketing + distribution of Ameluz in Spain by Allergan	2012-03-29
Altona Diagnostic–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project	2012-03-29
Altona Diagnostic–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project	2012-03-29
Altona Diagnostic–Leibniz-Gemeinschaft: molecular diagnostics, 201203– collab tropical diasease biobank + developm of respective tests ADT + BNI	2012-03-29
Leibniz-Gemeinschaft–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project	2012-03-29
Leibniz-Gemeinschaft–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project	2012-03-29
GATC Biotech–Hamilton: laboratory automation equipment, 201203 supply existent fleet of Hamilton robotics at GATC Cologence Sequencing Centre	2012-03-28
Promethera–Boehringer: investment, 201203 financing round Series B totalling €17m incl new investor Boehringer Ingelheim Venture Fund	2012-03-28
Promethera–SEVERAL: investment, 201203 financing round Series B €17m incl new investors Boehringer + Shire + Mitsui	2012-03-28
Univ Oslo–Thermo Fisher: mass spectrometer, 201203 supply Q-Exactive Orbitrap MS to Bioanalytics@UiO for proteomics + metabolomics applications	2012-03-28
Bayer–Tsinghua Univ: drug discovery, 201203– collab expansion over next 3 years	2012-03-27
Chugai–Genedata: bioinformatics, 201203– license multi-year extension for Genedata Expressionist s/w	2012-03-26
ImaginAb–Novartis: investment, 201203 financing round Series A totalling $12.5m incl lead investor Novartis Venture Funds	2012-03-26
ImaginAb–SEVERAL: investment, 201203 financing round Series A $12.5m led by Novartis Venture Funds	2012-03-26
Cytos Biotechnology–SEVERAL: investment, 201203 financing round of up to CHF37m in equity and debt led by venBio	2012-03-21
Evonik–Leibniz-Gemeinschaft: catalysts, 201203– collab extension long-term catalysis research with Leibniz Institute for Catalysis (LIKAT)	2012-03-21
Shimadzu–Sony: MALDI targets, 201203– collab extension developm application-specific + barcoded disposable MALDI targets by Kratos + Sony DADC	2012-03-21
Boehringer–Ablynx: Nanobodies, 201203–201409 collab extenstion 2y discovery up to 10 Nanobodies excl ww rights dev + manuf + marketing	2012-03-20
High-Tech Gründerfonds–Evonik: investment, 201203 investment of €2.5m in High-Tech Gründerfonds II	2012-03-20
CCS Cell Culture Service–ChromoTek: Chromobody cell lines, 201203– collab service + distribution + co-marketing by CCS	2012-03-15
CEVA–Minapharm: cell line, 201203– license €na multi-product to ProBioGen’s AGE1.CR avian cell line for production of viral animal vaccines	2012-03-15
EuroEPINOMICS project–Cartagenia: functional genomics, 201203– collab partner in RES project providing Cartagenia BENCH platform	2012-03-14
Univ Münster–Thermo Fisher: mass spectrometer, 201203 supply existent iCAP Q ICP-MS systems Karst group is early customer	2012-03-12
Bayer–Thompson Agronomics: soybeans, 201203 acquisition €na germplams assets of soybean breeding division ProSoy Genetics by Bayer CropScience	2012-03-09
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase Autoflex Speed MALDI TOF/TOF mass spectrometer by CNMN	2012-03-06
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase MicrOTOF-Q II ESI-Qq-TOF mass spectrometer by CNMN	2012-03-06
Affimed–SAW Instruments: sam Biosensor, 201203 supply existent Affimed is sam biosensor customer of SAW	2012-03-05
Biofrontera–Maschmeyer Group: investment, 201203 as part of €11.5m capital increase Alstin acquires resulting share of 12.5%	2012-03-02
Biofrontera–SEVERAL: investment, 201203 private placement capital increase €11.5m 4.4m new shares	2012-03-02
Boehringer–Biocrea: PDE-2 inhibitors, 201202– acquisition €na asset purchase of Biocrea’s PDE2 inhibitors incl lead compound BCA909	2012-02-29
Danaher–Epitomics: RabMab technology, 201202– collab supply long-term rabbit MAbs for automated ICH staining systems of Leica Biosystems	2012-02-29
Lundbeck–Paion: desmoteplase, 201202 acquisition all remaining desmoteplase rights for €20.1m in cash from Paion	2012-02-28
Origenis–Germany (govt): grant, 201202– 2-year grant within m4 Cluster program to develop biomarkers for developm of LRRK2 inhibitors	2012-02-28
Axolabs–Solvay: oligonucleotide drugs, 201202– collab strategic alliance combined services lead optimisation + manuf + analytical expertise Girindus	2012-02-27
OTHER–MorphoSys: Slonomics technology, 201202– supply 3y delivery of multiple Slonomics-based DNA libraries to large biopharma company	2012-02-27
Helmholtz–Bruker Corp: mass spectrometer, 201202 supply existent Ultraflex III MALDI-TOF-TOF at Proteomics Core Facility at Helmholtz München	2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4000 QTRAP at Proteomics Core Facility at Helmholtz-Zentrum München	2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4700 Proteomics Analyzer at Dept Protein Sciences at Helmholtz-Zentrum München	2012-02-26
Helmholtz–Thermo Fisher: mass spectrometer, 201202 supply existent LTQ Orbitrap XL at Proteomics Core Facility at Helmholtz-Zentrum München	2012-02-26
Apceth–Indivumed: biomarker, 201202– collab developm tissue-based markers for solid cancers to predict response to cell/gene therapy	2012-02-22
Kairos GmbH–Univ Bochum: CentraXX web portal platform, 201202– collab further development of platform with MPC	2012-02-22
Novartis–Enanta Pharmaceuticals: HCV drug, 201202– collab + license ww $34m upfront + $406m milestones + royalties NS5A inhibitor EDP-239	2012-02-21
Xencor–Boehringer: rec protein production, 201202– service + collab developm + manufacture + supply of mABs using Xtend technology for Xencor	2012-02-21
Bayer–Texas A&M Univ: wheat breeding, 201202– collab multi-year €na developm + commercialisation of new wheat varieties Texas AgriLife Research	2012-02-17
Seiratherm–Bavaria (govt): investment, 201202 financing round with investors HTGF + Bayern Kapital	2012-02-17
Seiratherm–High-Tech Gründerfonds: investment, 201202 financing round with investors HTGF + Bayern Kapital	2012-02-17
Seiratherm–SEVERAL: investment, 201202 financing round with HTGF + Bayern Kapital + strategic investor	2012-02-17
Evotec–IR Pharma: drug discovery services, 201202– collab excl strategic alliance €na integrated drug discovery solutions for respiratory diseases	2012-02-16
KMG Chemicals–Bayer: investment, 201202 acquisition €na animal insecticide business of KMG	2012-02-16
Univ Washington–Biognosys: iRT technology, 201202 collab product integration iRT concept implemented in Skyline s/w Vers 1.2	2012-02-16
BASF–Direvo Industrial Biotechnology: feed enzymes, 201202 acquisition of optimised mannanase enzyme by BASF Animal Nutrition business	2012-02-14
4DCellFate project–EU (govt): grant, 201202– 5y FP7 grant €12m	2012-02-13
Agilent–Eppendorf: thermal cycler, 201202– license covering gradient technology for thermal cyclers to Agilent	2012-02-13
OakLabs–High-Tech Gründerfonds: investment, 201202 seed investment from HTGF	2012-02-08
Ramcon–Anagnostics: hybcell products, 201202– collab excl distribution of hybcell tests in Scandinavia by Ramcon A/S	2012-02-08
Tecan–Artel: liquid handling technology, 201202– collab developm QC Kit for Freedom EVO based on Ratiometric Photometry technology	2012-02-06
Wilex–Germany (govt): grant, 201202– BMBF funding of up to €2.6m for developm of WX-037 within m4 Cluster Initiative	2012-02-06
Biofrontera–SEVERAL: investment, 201202 private placement capital increase €1.5m 500k new shares	2012-02-03
Merck (DE)–Threshold Pharmaceuticals: TH-302, 201202– co-developm + excl ww commercialistion €19m upfront + €41.5m milestones + double-digit royalties	2012-02-03
Anergis–Akampion: public relations, 201202 supply service existent	2012-02-01
BF Holding–SEVERAL: investment, 201202 capital increase MagForce AG €4.54m via 825.4k new shares at €5.5/share	2012-02-01
CovalX–Switzerland (govt): grant, 201202– KTI grant €300k for co-developm methods analysis of protein-protein interactions w Swiss academic partner	2012-02-01
Jacobs Univ–EU (govt): grant, 201202–201601 FP7 grant for Jacobs Univ as project partner + co-ordinator of €9m Micro B3 project	2012-02-01
Max Planck–EU (govt): grant, 201202–201601 FP7 grant for MPI for Marine Microbiology as partner of €9m Micro B3 project	2012-02-01
Micro B3 project–EU (govt): grant, 201202–201601 FP7 grant €9m to create integrative database on marine microorganisms	2012-02-01
Micro B3 project–Jacobs Univ: marine microorganism database, 201202–201601 collab Jacobs Univ is partner + co-ordinator of Micro B3 FP7 project	2012-02-01
Micro B3 project–Max Planck: marine microorganism database, 201202–201601 collab MPI for Marine Microbiology is project partner	2012-02-01
Micro B3 project–Ribocon: marine microorganism database, 201202–201601 collab Ribocon GmbH is project partner	2012-02-01
Ribocon–EU (govt): grant, 201202–201601 FP7 grant for Ribocon GmbH as partner of €9m Micro B3 project	2012-02-01
CeGat–B Braun: investment, 201201 acquisition of 20% share as part of strategic partnership to expand + internationalise CeGaT’s business	2012-01-31
Implandata–High-Tech Gründerfonds: investment, 201201 financing round Series A first closing totalling €1.4m incl investor HTGF	2012-01-30
Implandata–SEVERAL: investment, 201201 financing round Series A first closing €1.4m HTGF + Hannover Beteiligungsfonds + private investors	2012-01-30

1 2 3 ... 66 67 68  





» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.